BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18653346)

  • 1. Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls.
    Harness J; McCombe PA
    J Clin Neurosci; 2008 Sep; 15(9):1031-5. PubMed ID: 18653346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barré syndrome.
    Huang S; Li L; Liang S; Wang W
    J Neuroimmunol; 2009 Dec; 217(1-2):80-4. PubMed ID: 19853929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome.
    Pritchard J; Makowska A; Gregson NA; Hayday AC; Hughes RA
    J Neuroimmunol; 2007 Feb; 183(1-2):232-8. PubMed ID: 17239444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
    Hueman MT; Stojadinovic A; Storrer CE; Foley RJ; Gurney JM; Shriver CD; Ponniah S; Peoples GE
    Breast Cancer Res Treat; 2006 Jul; 98(1):17-29. PubMed ID: 16758122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
    Oling V; Marttila J; Knip M; Simell O; Ilonen J
    Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma.
    Gray CP; Arosio P; Hersey P
    Clin Cancer Res; 2003 Jul; 9(7):2551-9. PubMed ID: 12855630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
    Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
    Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
    Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M
    J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of the C-class chemokine lymphotactin (XCL1) in Wegener's granulomatosis.
    Blaschke S; Brandt P; Wessels JT; Müller GA
    J Rheumatol; 2009 Nov; 36(11):2491-500. PubMed ID: 19797511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis.
    Wei CM; Lee JH; Wang LC; Yang YH; Chang LY; Chiang BL
    J Microbiol Immunol Infect; 2008 Feb; 41(1):78-87. PubMed ID: 18327431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study.
    Kawikova I; Leckman JF; Kronig H; Katsovich L; Bessen DE; Ghebremichael M; Bothwell AL
    Biol Psychiatry; 2007 Feb; 61(3):273-8. PubMed ID: 16996487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
    Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.